RETATRUTIDE: ONE THOROUGH LOOK

The emerging class of GLP-1 receptor agonist and GIP combined medications, like tirzepatide, semaglutide, and the recently introduced retatrutide, offer significant improvements in diabetes control. Although all three work by modulating sugar concentrations, they differ in their specific mechanis